It functions as a coenzyme in the metabolism of carbohydrates, fats, and proteins, helping the body convert nutrients into usable energy
Meal timing and frequency also matter
This hormone is released in the gut after eating and plays a key role in regulating blood sugar and appetite
For sublingual use only
This leaves many patients unaware of how taking Ozempic could lead to these dangerous medical conditions
Key TakeawaysThe number of people taking GLP-1 drugs to lose weight more than tripled in recent yearsThe percentage of non-diabetics taking GLP-1 drugs rose from 0.1% to 0.4% between 2018 and 2022That led to $5.8 billion in spending on the drugs in 2022.TUESDAY, April 1, 2025 (HealthDay News) -- The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent years, a new study says.The number of people without diabetes taking a GLP-1 drug more than tripled between 2018 and 2022 in the U.S., researchers reported March 31 in the Annals of Internal Medicine.Spending on these drugs reached $5.8 billion in 2022, with average prices consistently exceeding $1,500 per prescription, results show.Despite this, adoption remained limited, as only 1 in 250 U.S
